Glen Eagle Advisors’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-200
Closed -$4.7K 914
2019
Q4
$4.7K Hold
200
﹤0.01% 723
2019
Q3
$3.6K Hold
200
﹤0.01% 669
2019
Q2
$3.13K Sell
200
-490
-71% -$9.64K ﹤0.01% 667
2019
Q1
$15.7K Buy
690
+100
+17% +$2.25K 0.01% 416
2018
Q4
$13.7K Hold
590
0.01% 415
2018
Q3
$19.5K Buy
590
+185
+46% +$6.91K 0.01% 380
2018
Q2
$17.8K Sell
405
-60
-13% -$2.32K 0.01% 377
2018
Q1
$19.4K Buy
465
+95
+26% +$4.39K 0.02% 347
2017
Q4
$16.8K Buy
+370
New +$14.6K 0.01% 361

Other funds holding PETS

Glen Eagle Advisors's PETS Position: Q1 2020 in Review

Glen Eagle Advisors sold out of PetMed Express (PETS) in Q1 2020, closing a stake of 200 shares — an estimated $4.7K sold.

Glen Eagle Advisors first reported a position in PETS in Q4 2017 and held it in 9 quarters. The position peaked at $19.5K in Q3 2018. 202 funds tracked by Wall St. Rank hold PETS as of Q1 2020.

  • Glen Eagle Advisors reported no remaining PetMed Express position as of Q1 2020 after selling out during the quarter.
  • Glen Eagle Advisors sold 200 PetMed Express shares in Q1 2020, an estimated $4.7K.
  • Glen Eagle Advisors first reported a position in PetMed Express in Q4 2017 and held it in 9 quarters.
  • Glen Eagle Advisors's PetMed Express position peaked at $19.5K in Q3 2018.
  • 202 funds tracked by Wall St. Rank held PetMed Express as of Q1 2020.

Based on Glen Eagle Advisors's 13F filing for Q1 2020, filed 13 Aug 2024.